TABLE 1.
(a) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Proximal | Distal | |||||||||||
AVP | OT | AVP | OT | |||||||||
Effect | Threshold (M) | pEC50 | Emax (%) | Threshold (M) | pEC50 | Emax (%) | Threshold (M) | pEC50 | Emax (%) | Threshold (M) | pEC50 | Emax (%) |
Tone | 10−11–10−10 | 9.5 ± 0.2 | 7.1 ± 0.2 | 10−9–10−8 | 7.5 ± 0.0 | 4.4 ± 0.1 | 10−11–10−10 | 9.5 ± 0.1 | 9.5 ± 0.2 | 10−9–10−8 | 7.1 ± 0.1 | 6.3 ± 0.12 |
Amplitude | 10−11–10−10 | 9.5 ± 0.1 | 244.8 ± 3.9 | 10−8 | 7.2 ± 0.1 | 145.6 ± 2.3 | 10−10 | 9.0 ± 0.1 | 55.0 ± 2.0 | 10−9–10−8 | 7.4 ± 0.1 | 51.5 ± 1.5 |
Frequency | 10−11–10−10 | 8.9 ± 0.1 | 30.4 ± 2.6 | 10−9–10−8 | 7.4 ± 0.1 | 30.0 ± 2.6 | 10−11–10−10 | 9.0 ± 0.1 | 33.6 ± 1.0 | 10−9–10−8 | 7.2 ± 0.2 | 30.5 ± 2.5 |
(b) | |||||
---|---|---|---|---|---|
Proximal | Distal | ||||
Experimental condition | Effect | pEC50 | Emax (%) | pEC50 | Emax (%) |
Baseline conditions | Tone (contraction) | 9.5 ± 0.2 | 6.3 ± 0.5 | 9.3 ± 0.1 | 7.6 ± 0.5 |
Tone (relaxation) | 5.1 ± 0.2 | 100 | 5.1 ± 0.2 | 100 | |
Amplitude | 8.6 ± 0.1 | 244.3 ± 10.2 | 8.7 ± 0.1 | 56.4 ± 3.8 | |
Frequency | 7.6 ± 0.4 | 23.4 ± 1.9 | 8.1 ± 0.4 | 25.2 ± 1.2 | |
EFS conditions | Tone (contraction) | 8.9 ± 0.1 | 5.1 ± 0.3 | 9.0 ± 0.1 | 6.4 ± 0.4 |
Tone (relaxation) | 5.4 ± 0.2 | 100 | 4.8 ± 0.1 | 100 | |
EFS‐evoked contraction inhibition | 5.9 ± 0.2 | 58.8 ± 4.9 | 6.2 ± 0.1 | 73.4 ± 4.0 |
Note: Data are mean ± SEM. (a) n = 5. (b) n = 4.
Abbreviations: AVP, arginine vasopressin; EFS, electrical field stimulation; OT, oxytocin.